Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections (Q40666918)

22 September 2017

Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections (English)

1 reference

22 September 2017

1 reference

1 reference

1 reference

3

John W Huggins

1 reference

22 September 2017

2

Mike Bray

1 reference

22 September 2017

Robert O Baker

1

1 reference

22 September 2017

1 January 2003

1 reference

22 September 2017

1 reference

22 September 2017

57

1 reference

22 September 2017

1-2

1 reference

22 September 2017

13-23

1 reference

Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

3-deazaneplanocin A induces massively increased interferon-alpha production in Ebola virus-infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

S-adenosylhomocysteine hydrolase inhibitors as broad-spectrum antiviral agents

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Antiviral agents: characteristic activity spectrum depending on the molecular target with which they interact.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Antivirals for the treatment of herpesvirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Broad-spectrum antiviral activity of the carbocyclic analog of 3-deazaadenosine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Effect of cytosine, arabinoside, iododeoxyuridine, ethyldeoxyuridine, thiocyanatodeoxyuridine, and ribavirin on tail lesion formation in mice infected with vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Dye Uptake Methods for Assessing Viral Cytopathogenicity and their Application to Interferon Assays

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

The sequence of camelpox virus shows it is most closely related to variola virus, the cause of smallpox

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Therapeutic developments in cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Antiviral drug therapy of filovirus infections: S-adenosylhomocysteine hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Inhibition of vaccinia virus growth by the nucleoside analogue 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ribavirin)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Progressive vaccinia treated with ribavirin and vaccinia immune globulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Cytomegalovirus treatment options in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Broad-spectrum synergistic antiviral activity of selenazofurin and ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Synthesis and antiviral evaluation of analogs of adenosine-N1-oxide and 1-(Benzyloxy)adenosine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Regulation of proliferation of LLC-MK2 cells by nucleosides and nucleotides: the role of ecto-enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Analysis of the complete genome of smallpox variola major virus strain Bangladesh-1975.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Carbocyclic analogue of 3-deazaadenosine: a novel antiviral agent using S-adenosylhomocysteine hydrolase as a pharmacological target

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

1 reference

7 January 2021

Potentiating effect of ribavirin on the anti-herpes activity of acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Studies on the mechanism of the antiviral activity of ribavirin against reovirus.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Cytomegalovirus infection: the point in 2001.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Human and primate poxviruses: I. Growth characteristics of cytolytic and tumor variants

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Treatment of cowpox virus respiratory infections in mice with ribavirin as a single agent or followed sequentially by cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

Chemotherapeutic prevention of complications caused by vaccinia virus-vectored immunogen

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900196-1

7 January 2021

10.1016/S0166-3542(02)00196-1

Identifiers

DOI

1 reference

release_ewetdbgxhzbmxhumd2pilesrlm

22 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ewetdbgxhzbmxhumd2pilesrlm

24 November 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/ewetdbgxhzbmxhumd2pilesrlm

24 November 2022

mapped directly with Wikidata item

PubMed ID

12615299

1 reference

PubMed ID

12615299